Skip to content

The DREAMS study: A prospective observational study on the first weeks of PAP treatment for obstructive sleep apnea

The DREAMS study: A prospective observational study on the first weeks of PAP treatment for obstructive sleep apnea - A prospective observational study on PAP treatment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON56944
Enrollment
150
Registered
2024-08-06
Start date
2025-03-25
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

slaapstoornissen Sleep apnea sleep disordered breathing

Interventions

None listed

Sponsors

Kempenhaeghe
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Age older than 18 • Diagnosis of OSA • Speaking and reading Dutch  • Written informed consent • PAP treatment is prescribed for the first time • Attend a PAP-initiation meeting • PSG, PG or WatchPAT recording available • Online intake questionnaire available

Exclusion criteria

Exclusion criteria: • Suspicion of complex comorbid (sleep)disorders (as indicated by the clinical  sleep expert).  • (Suspicion of) underlying severe neurological or psychiatric disorders,  presence of persistent heart rhythm disorders, presence of autonomic  dysfunction. • Known allergies for hard plastic (like in sport watches) or wristband material • Presence of wounds, injuries, or inflammation on the skin where the wristband  will be placed • Tattoo on top of the wrist or head (where the sensor should be placed) • Pregnancy  • Working in (rotating) night shifts • Inability to adhere to the study protocol

Design outcomes

Primary

MeasureTime frame
Patient demographics and medical information, treatment information (e.g., PAP readout), wearable-derived sleep parameters

Secondary

MeasureTime frame
Ambulatory PSG/PG/Watchpad-derived parameter, digital sleep diary, questionnaires

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)